Clinical Trials in Texas

Showing 10101-10120 of 11,487 trials

The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects

NCT00146289

The primary objective of this study is to determine whether MICARDIS® improves insulin sensitivity in overweight or obese, non-diabetic, normotensive subjects.

ObesityInsulin Resistance

Boehringer Ingelheim138 participantsStarted Feb 2005

Los Angeles, California, United States • San Diego, California, United States • Westlake Village, California, United States +14 more locations

COMPLETEDPhase 313 miles

Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases

NCT00003563

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Gadolinium texaphyrin may increase the effectiveness of radiation therapy by making tumor cells more sensitive to radiation. It is not yet known whether giving gadolinium texaphyrin with radiation therapy is more effective than radiation therapy alone in treating brain metastases. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without gadolinium texaphyrin in treating patients who have brain metastases.

Metastatic Cancer

Pharmacyclics LLC.430 participantsStarted Aug 1998

Greenbrae, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +32 more locations

The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects

Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases

Find Trials by Condition in Texas

Diabetes Self-Management Models to Reduce Health Disparities

A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy

Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors

A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS

Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients

A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)

Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols

A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

Study of Quadrivalent Influenza Vaccine Among Adults

Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC

A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist